VODOBATINIB FOR REDUCING PROGRESSION OF PARKINSON'S DISEASE
The present disclosure relates to the c-Abl inhibitor vodobatinib, or a pharmaceutically acceptable salt thereof, for use in treating, delaying, inhibiting, or suppressing the progression of neurodegenerative diseases, preferably early stage Parkinson's disease, in a subject. La présente invent...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | GOLDFINE, Andrew YAO, Siu-Long TALLURI, Ravi Sankar Prasad DAMLE, Nitin Krishnaji MANDHANE, Sanjay Nandlalji RAMANATHAN, Vikram Krishna FAULKNER, Robert D |
| description | The present disclosure relates to the c-Abl inhibitor vodobatinib, or a pharmaceutically acceptable salt thereof, for use in treating, delaying, inhibiting, or suppressing the progression of neurodegenerative diseases, preferably early stage Parkinson's disease, in a subject.
La présente invention concerne l'inhibiteur de c-Abl vodobatinib, ou un sel pharmaceutiquement acceptable de celui-ci, destiné à être utilisé pour traiter, retarder, inhiber ou empêcher la progression de maladies neurodégénératives, de préférence de la maladie de Parkinson au stade précoce, chez un sujet. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2023214314A9</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2023214314A9</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2023214314A93</originalsourceid><addsrcrecordid>eNrjZLAO83fxd3IM8fTzdFJw8w9SCHJ1CXX29HNXCAjydw9yDQ729PdT8HdTCHAM8vb0C_b3Uw9WcPEMdnUMduVhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRsZGhibGhiaOlsbEqQIAlBUqVA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>VODOBATINIB FOR REDUCING PROGRESSION OF PARKINSON'S DISEASE</title><source>esp@cenet</source><creator>GOLDFINE, Andrew ; YAO, Siu-Long ; TALLURI, Ravi Sankar Prasad ; DAMLE, Nitin Krishnaji ; MANDHANE, Sanjay Nandlalji ; RAMANATHAN, Vikram Krishna ; FAULKNER, Robert D</creator><creatorcontrib>GOLDFINE, Andrew ; YAO, Siu-Long ; TALLURI, Ravi Sankar Prasad ; DAMLE, Nitin Krishnaji ; MANDHANE, Sanjay Nandlalji ; RAMANATHAN, Vikram Krishna ; FAULKNER, Robert D</creatorcontrib><description>The present disclosure relates to the c-Abl inhibitor vodobatinib, or a pharmaceutically acceptable salt thereof, for use in treating, delaying, inhibiting, or suppressing the progression of neurodegenerative diseases, preferably early stage Parkinson's disease, in a subject.
La présente invention concerne l'inhibiteur de c-Abl vodobatinib, ou un sel pharmaceutiquement acceptable de celui-ci, destiné à être utilisé pour traiter, retarder, inhiber ou empêcher la progression de maladies neurodégénératives, de préférence de la maladie de Parkinson au stade précoce, chez un sujet.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231214&DB=EPODOC&CC=WO&NR=2023214314A9$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231214&DB=EPODOC&CC=WO&NR=2023214314A9$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GOLDFINE, Andrew</creatorcontrib><creatorcontrib>YAO, Siu-Long</creatorcontrib><creatorcontrib>TALLURI, Ravi Sankar Prasad</creatorcontrib><creatorcontrib>DAMLE, Nitin Krishnaji</creatorcontrib><creatorcontrib>MANDHANE, Sanjay Nandlalji</creatorcontrib><creatorcontrib>RAMANATHAN, Vikram Krishna</creatorcontrib><creatorcontrib>FAULKNER, Robert D</creatorcontrib><title>VODOBATINIB FOR REDUCING PROGRESSION OF PARKINSON'S DISEASE</title><description>The present disclosure relates to the c-Abl inhibitor vodobatinib, or a pharmaceutically acceptable salt thereof, for use in treating, delaying, inhibiting, or suppressing the progression of neurodegenerative diseases, preferably early stage Parkinson's disease, in a subject.
La présente invention concerne l'inhibiteur de c-Abl vodobatinib, ou un sel pharmaceutiquement acceptable de celui-ci, destiné à être utilisé pour traiter, retarder, inhiber ou empêcher la progression de maladies neurodégénératives, de préférence de la maladie de Parkinson au stade précoce, chez un sujet.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAO83fxd3IM8fTzdFJw8w9SCHJ1CXX29HNXCAjydw9yDQ729PdT8HdTCHAM8vb0C_b3Uw9WcPEMdnUMduVhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRsZGhibGhiaOlsbEqQIAlBUqVA</recordid><startdate>20231214</startdate><enddate>20231214</enddate><creator>GOLDFINE, Andrew</creator><creator>YAO, Siu-Long</creator><creator>TALLURI, Ravi Sankar Prasad</creator><creator>DAMLE, Nitin Krishnaji</creator><creator>MANDHANE, Sanjay Nandlalji</creator><creator>RAMANATHAN, Vikram Krishna</creator><creator>FAULKNER, Robert D</creator><scope>EVB</scope></search><sort><creationdate>20231214</creationdate><title>VODOBATINIB FOR REDUCING PROGRESSION OF PARKINSON'S DISEASE</title><author>GOLDFINE, Andrew ; YAO, Siu-Long ; TALLURI, Ravi Sankar Prasad ; DAMLE, Nitin Krishnaji ; MANDHANE, Sanjay Nandlalji ; RAMANATHAN, Vikram Krishna ; FAULKNER, Robert D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2023214314A93</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GOLDFINE, Andrew</creatorcontrib><creatorcontrib>YAO, Siu-Long</creatorcontrib><creatorcontrib>TALLURI, Ravi Sankar Prasad</creatorcontrib><creatorcontrib>DAMLE, Nitin Krishnaji</creatorcontrib><creatorcontrib>MANDHANE, Sanjay Nandlalji</creatorcontrib><creatorcontrib>RAMANATHAN, Vikram Krishna</creatorcontrib><creatorcontrib>FAULKNER, Robert D</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GOLDFINE, Andrew</au><au>YAO, Siu-Long</au><au>TALLURI, Ravi Sankar Prasad</au><au>DAMLE, Nitin Krishnaji</au><au>MANDHANE, Sanjay Nandlalji</au><au>RAMANATHAN, Vikram Krishna</au><au>FAULKNER, Robert D</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>VODOBATINIB FOR REDUCING PROGRESSION OF PARKINSON'S DISEASE</title><date>2023-12-14</date><risdate>2023</risdate><abstract>The present disclosure relates to the c-Abl inhibitor vodobatinib, or a pharmaceutically acceptable salt thereof, for use in treating, delaying, inhibiting, or suppressing the progression of neurodegenerative diseases, preferably early stage Parkinson's disease, in a subject.
La présente invention concerne l'inhibiteur de c-Abl vodobatinib, ou un sel pharmaceutiquement acceptable de celui-ci, destiné à être utilisé pour traiter, retarder, inhiber ou empêcher la progression de maladies neurodégénératives, de préférence de la maladie de Parkinson au stade précoce, chez un sujet.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2023214314A9 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | VODOBATINIB FOR REDUCING PROGRESSION OF PARKINSON'S DISEASE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T17%3A38%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GOLDFINE,%20Andrew&rft.date=2023-12-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2023214314A9%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |